Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2026-01-01 @ 5:19 AM
Study NCT ID:
NCT03996369
Status:
COMPLETED
Last Update Posted:
2022-12-21
First Post:
2019-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
Sponsor:
Arena Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-07
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-21
First Submit QC Date:
None
Study First Post Date:
2019-06-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-11-28
Results First Submit QC Date:
None
Results First Post Date:
2022-12-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-28
Last Update Post Date:
2022-12-21
Last Update Post Date Type:
ACTUAL